Patient-reported cognitive function among hematopoietic stem cell transplant and cellular therapy patients: a scoping review.
Adult
Cellular therapy
Cognitive function
Hematopoietic stem cell transplant
Patient-reported outcomes
Journal
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
accepted:
12
09
2022
pmc-release:
01
04
2024
medline:
3
4
2023
pubmed:
7
10
2022
entrez:
6
10
2022
Statut:
ppublish
Résumé
Cognitive dysfunction is a known complication following cellular therapies (CT), which can be assessed through performance based and patient-reported measures. We performed a systematic scoping review to assess self-reported cognitive function measures used among adult CT patients and describe long-term results, including associations with clinical outcomes. Library databases were searched from inception to February 2020 according to PRISMA guidelines. Additional studies were identified through reference lists and trial protocols. Two members of the research team screened titles and abstracts and resolved discrepancies. Articles that met eligibility criteria continued to full-text review, with 25% double screening. Articles were removed if they (1) were not original research, peer-reviewed articles; (2) were the wrong disease, age, or treatment-specific patient population; (3) did not use patient-reported outcomes; (4) did not separately report cognitive function outcomes. Of the1952 articles, 56 were included. Twenty-one patient-reported measures of cognitive function were used; most frequently the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ-C30), which includes a two-item cognitive function subscale (57%; n = 32). Thirteen studies collected performance-based and self-reported measures and of those (n = 6) who assessed associations found moderate correlations (range r = .13-.58). Longitudinal patterns showed declines in cognitive function soon after treatment (< 1 month) returning to baseline at 1 year. Cognitive function was often associated with other quality of life measures, chiefly depression (n = 5). EORTC-QLQ-C30 is the most commonly used to measure, though there remain numerous measures used, including several measures with little previous validation and investigator developed items.
Identifiants
pubmed: 36203005
doi: 10.1007/s11136-022-03258-0
pii: 10.1007/s11136-022-03258-0
pmc: PMC10259487
mid: NIHMS1894209
doi:
Types de publication
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
939-964Subventions
Organisme : NCI NIH HHS
ID : U24 CA076518
Pays : United States
Organisme : NCI NIH HHS
ID : U24CA076518
Pays : United States
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Références
Bone Marrow Transplant. 1990 Oct;6(4):269-76
pubmed: 2085701
J Clin Oncol. 2007 Nov 10;25(32):5106-12
pubmed: 17991929
J Pain Symptom Manage. 2009 Aug;38(2):174-90
pubmed: 19345060
CNS Drugs. 2018 Dec;32(12):1091-1101
pubmed: 30387077
Bone Marrow Transplant. 1989 Sep;4(5):505-9
pubmed: 2790328
Bone Marrow Transplant. 2016 Jun;51(6):841-7
pubmed: 26926230
Cancer. 2013 Dec 1;119(23):4188-95
pubmed: 24105672
Bone Marrow Transplant. 2014 Jun;49(6):786-92
pubmed: 24710562
Support Care Cancer. 2007 Jul;15(7):849-57
pubmed: 17205276
Lancet Haematol. 2019 Feb;6(2):e89-e99
pubmed: 30709437
PLoS One. 2017 Jul 20;12(7):e0181313
pubmed: 28727771
Blood Adv. 2020 Feb 25;4(4):629-637
pubmed: 32074277
Bone Marrow Transplant. 2007 Jun;39(12):789-99
pubmed: 17417661
Cancer. 2000 Oct 1;89(7):1634-46
pubmed: 11013380
BMC Cancer. 2013 Mar 28;13:165
pubmed: 23537330
Cancer. 2009 Oct 1;115(19):4625-35
pubmed: 19551887
Bone Marrow Transplant. 2018 May;53(5):535-555
pubmed: 29343837
Leuk Lymphoma. 2012 Mar;53(3):386-93
pubmed: 21864036
Support Care Cancer. 2018 Mar;26(3):833-841
pubmed: 28918604
Eur J Cancer. 2005 May;41(7):1007-16
pubmed: 15862749
Biol Blood Marrow Transplant. 2010 Jun;16(6):824-31
pubmed: 20100587
J Clin Oncol. 2007 Apr 10;25(11):1403-11
pubmed: 17416860
Oncol Nurs Forum. 2006 May 03;33(3):614-24
pubmed: 16676017
Bone Marrow Transplant. 2017 Feb;52(2):279-284
pubmed: 27941775
J Alzheimers Dis. 2019;70(4):1225-1239
pubmed: 31322557
J Neurooncol. 2019 Sep;144(3):553-562
pubmed: 31377920
Bone Marrow Transplant. 1999 Oct;24(8):911-8
pubmed: 10516705
Oncol Nurs Forum. 2004 Sep 17;31(5):937-44
pubmed: 15378094
Biol Blood Marrow Transplant. 2020 Jan;26(1):34-43
pubmed: 31605820
Oncol Nurs Forum. 2011 Sep;38(5):582-6
pubmed: 21875845
Blood. 1998 May 15;91(10):3637-45
pubmed: 9572999
Biol Blood Marrow Transplant. 2019 May;25(5):e155-e162
pubmed: 30500439
Bone Marrow Transplant. 2002 Dec;30(11):785-92
pubmed: 12439702
Support Care Cancer. 2013 Feb;21(2):599-607
pubmed: 22886429
Arch Clin Neuropsychol. 2021 Oct 13;36(7):1341-1349
pubmed: 33454756
J Pain Symptom Manage. 2014 Sep;48(3):374-84
pubmed: 24529631
Eur J Intern Med. 2002 Feb;13(1):52-56
pubmed: 11836083
J Clin Oncol. 1999 Feb;17(2):706-18
pubmed: 10080617
Psychooncology. 2011 Jan;20(1):88-97
pubmed: 20187072
Bone Marrow Transplant. 2010 Apr;45(4):746-54
pubmed: 19718073
Biol Blood Marrow Transplant. 2017 Jan;23(1):140-146
pubmed: 27751934
Eur J Cancer. 2007 Sep;43(14):2052-9
pubmed: 17719220
Psychooncology. 2014 Dec;23(12):1406-14
pubmed: 24846770
Psychiatry Res. 2015 Mar 30;226(1):169-72
pubmed: 25639374
Bone Marrow Transplant. 2005 Oct;36(8):695-702
pubmed: 16086044
Psychooncology. 2014 Oct;23(10):1133-41
pubmed: 24700645
Transplant Cell Ther. 2021 May;27(5):390.e1-390.e7
pubmed: 33965176
J Natl Cancer Inst. 2021 Nov 29;113(12):1625-1633
pubmed: 33638633
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Cancer. 2002 Jul 1;95(1):183-92
pubmed: 12115332
J Pain Symptom Manage. 2007 Jan;33(1):13-23
pubmed: 17196903
Bone Marrow Transplant. 2014 Sep;49(9):1217-22
pubmed: 25000458
Bone Marrow Transplant. 2006 Jan;37(2):165-9
pubmed: 16299541
Blood. 2013 Feb 28;121(9):1517-23
pubmed: 23297129
Biol Blood Marrow Transplant. 2019 Apr;25(4):625-638
pubmed: 30592986
Palliat Support Care. 2014 Feb;12(1):53-61
pubmed: 24169207
Med Care. 2007 May;45(5 Suppl 1):S3-S11
pubmed: 17443116
Patient Relat Outcome Meas. 2017 Mar 15;8:33-42
pubmed: 28352208
Bone Marrow Transplant. 2012 Dec;47(12):1545-51
pubmed: 22580768
Palliat Support Care. 2019 Aug;17(4):396-402
pubmed: 30238868
Psychooncology. 2012 Nov;21(11):1175-84
pubmed: 21739524
Biol Blood Marrow Transplant. 2000;6(5A):576-91
pubmed: 11071263
Bone Marrow Transplant. 2014 Feb;49(2):292-8
pubmed: 24096825
Cancer. 2012 Jul 1;118(13):3407-16
pubmed: 22139882
J BUON. 2009 Oct-Dec;14(4):673-80
pubmed: 20148461
J Clin Oncol. 2019 Jul 1;37(19):1617-1628
pubmed: 30969846
Bone Marrow Transplant. 2004 Sep;34(6):545-56
pubmed: 15343272
Eur J Cancer. 2007 Jan;43(1):87-94
pubmed: 17081744
Support Care Cancer. 2015 Jul;23(7):2157-64
pubmed: 25556704
Cancer. 2002 Nov 1;95(9):1971-81
pubmed: 12404292
Cancer Treat Rev. 2012 Nov;38(7):926-34
pubmed: 22658913
Eur J Cancer. 2004 May;40(7):971-8
pubmed: 15093571
Oncologist. 2008 Dec;13(12):1285-95
pubmed: 19019972